Arsenic trioxide and breast cancer: Analysis of the apoptotic, differentiative and immunomodulatory effects

Breast Cancer Research and Treatment

Volumn 73, Issue 1, 2002, Pages 61-73

  Baj, Germano ^a,b   Arnulfo, Alberto ^a   Deaglio, Silvia ^c   Mallone, Roberto ^c   Vigone, Alessandro ^a   De Cesaris, Maria Grazia ^d   Surico, Nicola ^a,b   Malavasi, Fabio ^c   Ferrero, Enza ^c  

^a Laboratories of Gynecologic Oncology   (Italy)

^b MAGGIORE DELLA CARITÀ HOSPITAL   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

^d UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

Apoptosis; Arsenic trioxide; Breast; Carcinoma; Differentiation; Immunomodulation

Indexed keywords

ARSENIC TRIOXIDE; INTERCELLULAR ADHESION MOLECULE 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; LYMPHOKINE; GLUTATHIONE; IMMUNOLOGICAL ADJUVANT; ORGANOARSENIC DERIVATIVE; OXIDE; THIOL DERIVATIVE;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER MODEL; CELL DEATH; CELL DIFFERENTIATION; CELL VIABILITY; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXICITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOMODULATION; LYMPHOKINE ACTIVATED KILLER CELL; PRIORITY JOURNAL; BREAST TUMOR; CELL CULTURE; CELL DIVISION; COMPARATIVE STUDY; DRUG EFFECT; DRUG RESISTANCE; FLUORESCENT ANTIBODY TECHNIQUE; IN VITRO STUDY; METABOLISM; PATHOLOGY; PHYSIOLOGY; PROTO ONCOGENE; WESTERN BLOTTING;

ADJUVANTS, IMMUNOLOGIC; APOPTOSIS; ARSENICALS; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL DIFFERENTIATION; CELL DIVISION; COMPARATIVE STUDY; DRUG RESISTANCE, NEOPLASM; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GENES, BCL-2; GLUTATHIONE; HUMAN; IN VITRO; INTERCELLULAR ADHESION MOLECULE-1; KILLER CELLS, LYMPHOKINE-ACTIVATED; LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1; OXIDES; SULFHYDRYL COMPOUNDS; SUPPORT, NON-U.S. GOV'T; TUMOR CELLS, CULTURED; HUMANS;

EID: 0035985485     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1015272401822     Document Type: Article

References (34)

1. Arsenicals in hematologic cancers
2. Arsenic trioxide and melarsoprol induce apoptosis in plasma cell lines and in plasma cells from myeloma patients
3. Apoptosis and growth inhibition in malignant lymphocytes after treatment with arsenic trioxide at clinically achievable concentrations
4. Arsenic trioxide sensitivity is associated with low level of glutathione in cancer cells
5. Induction of apoptosis and inhibition of human gastric cancer MGC-803 cell growth by arsenic trioxide
6. The alteration of mitochondria is an early event of arsenic trioxide induced apoptosis in esophageal carcinoma cells
7. Arsenic trioxide induces apoptosis in neuroblastoma cell lines through the activation of caspase 3 in vitro
8. Arsenic trioxide-mediated cytotoxicity and apoptosis in prostate and ovarian carcinoma cell lines
9. 3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients
10. Retinoids in breast cancer prevention and treatment. A review of the literature
11. Retinoic acid, receptor α expression correlates with retinoid-induced growth of human breast cancer regardless of estrogen receptor status
12. 20-Epi-vitamin D3 analogues: A novel class of potent inhibitors of proliferation and inducers of differentiation of human breast cancer cell lines
13. Decreased expression of ICAM-1 and its induction by tumour necrosis factor on breast-cancer cells in vitro
14. Expression of intercellular adhesion molecule-1 in invasive breast cancer reflects low growth potential, negative lymph node involvement, and good prognosis
15. Natural killer cell cytotoxicity of breast cancer targets is enhanced by two distinct mechanisms of antibody-dependent cellular cytotoxicity against LFA-3 and HER2/neu
16. All-trans retinoic acid inhibits the growth of breast cancer cells by up-regulating ICAM-1 expression
17. Evidence of an immunologic mechanism behind the therapeutical effects of arsenic trioxide on myeloma cells
18. 3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RAR alpha/PML proteins
19. Arsenic trioxide induces apoptosis in human gastric cancer cells through up-regulation of p53 and activation of caspase-3
20. Arsenic trioxide, a novel mitochondriotoxic anticancer agent?
21. Malignant cells can be sensitized to undergo growth inhibition and apoptosis by arsenic trioxide through modulation of the gluthathione redox system
22. Arsenic trioxide selectively induces acute promyelocytic leukemia cell apoptosis via a hydrogen peroxide-dependent pathway
23. Human CD38 (ADP-Ribosyl Cyclase) is a counter-receptor of CD31, an Ig superfamily member
24. Oxytocin receptors in human adenocarcinomas of the endometrium: Presence and biological significance
25. Characterization of a CD38-like 78-kilodalton soluble protein released from B cell lines derived from patients with X-linked agammaglobulinemia
26. Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent
27. Lipid peroxidation and irreversible damage in the rat hepatocyte model. Protection by the silybin-phospholipid complex IdB 1016
28. Effects of all-trans-retinoic acid and 13-cis-retinoic acid on breast-cancer cell lines: Growth inhibition and apoptosis induction
29. Role of CD38 and its ligand in the regulation of MHC-nonrestricted cytotoxic T cells
30. Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide
31. Bc1-xL acts downstream of caspase-8 activation by the CD95 death-inducing signaling complex
32. Expression and stability of p53 protein in normal human mammary epithelial cells
33. Cadmium induces conformational modifications of wild-type p53 and suppresses p53 response to DNA damage in cultured cells
34. Estradiol induces functional inactivation of p53 by intracellular redistribution